Department of Anesthesiology
[ Author(Desc)] Title Type Year
Filters: Keyword is Animals  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
K
Kim SHyun, Ryan TA.  2013.  Balance of calcineurin Aα and CDK5 activities sets release probability at nerve terminals.. J Neurosci. 33(21):8937-50.
Kim SHyun, Ryan TA.  2010.  CDK5 serves as a major control point in neurotransmitter release.. Neuron. 67(5):797-809.
King MM, Huang CY, Chock PB, Nairn AC, Hemmings HC, Chan KF, Greengard P.  1984.  Mammalian brain phosphoproteins as substrates for calcineurin.. J Biol Chem. 259(13):8080-3.
Koyama M, Heerdt PM, Levi R.  2003.  Increased severity of reperfusion arrhythmias in mouse hearts lacking histamine H3-receptors.. Biochem Biophys Res Commun. 306(3):792-6.
Ku EC, Lee W, Kothari HV, Kimble EF, Liauw L, Tjan J.  1985.  The effects of diclofenac sodium on arachidonic acid metabolism.. Semin Arthritis Rheum. 15(2 Suppl 1):36-41.
Kyrozis A, Goldstein PA, Heath MJ, MacDermott AB.  1995.  Calcium entry through a subpopulation of AMPA receptors desensitized neighbouring NMDA receptors in rat dorsal horn neurons.. J Physiol. 485 ( Pt 2):373-81.
L
Lansky S, Wang Z, Clarke OB, Chipot C, Scheuring S.  2025.  Structural dynamics and permeability of the TRPV3 pentamer.. Nat Commun. 16(1):4520.
Levin EJ, Elsen NL, Seder KD, McCoy JG, Fox BG, Phillips GN.  2008.  X-ray structure of a soluble Rieske-type ferredoxin from Mus musculus.. Acta Crystallogr D Biol Crystallogr. 64(Pt 9):933-40.
Liantonio A, De Luca A, Pierno S, Didonna MPaola, Loiodice F, Fracchiolla G, Tortorella P, Antonio L, Bonerba E, Traverso S et al..  2003.  Structural requisites of 2-(p-chlorophenoxy)propionic acid analogues for activity on native rat skeletal muscle chloride conductance and on heterologously expressed CLC-1.. Br J Pharmacol. 139(7):1255-64.
Liantonio A, Giannuzzi V, Picollo A, Babini E, Pusch M, D Camerino C.  2007.  Niflumic acid inhibits chloride conductance of rat skeletal muscle by directly inhibiting the CLC-1 channel and by increasing intracellular calcium.. Br J Pharmacol. 150(2):235-47.
Liantonio A, Pusch M, Picollo A, Guida P, De Luca A, Pierno S, Fracchiolla G, Loiodice F, Tortorella P, Camerino DConte.  2004.  Investigations of pharmacologic properties of the renal CLC-K1 chloride channel co-expressed with barttin by the use of 2-(p-Chlorophenoxy)propionic acid derivatives and other structurally unrelated chloride channels blockers.. J Am Soc Nephrol. 15(1):13-20.
Liantonio A, Picollo A, Carbonara G, Fracchiolla G, Tortorella P, Loiodice F, Laghezza A, Babini E, Zifarelli G, Pusch M et al..  2008.  Molecular switch for CLC-K Cl- channel block/activation: optimal pharmacophoric requirements towards high-affinity ligands.. Proc Natl Acad Sci U S A. 105(4):1369-73.
Liantonio A, Picollo A, Babini E, Carbonara G, Fracchiolla G, Loiodice F, Tortorella V, Pusch M, Camerino DConte.  2006.  Activation and inhibition of kidney CLC-K chloride channels by fenamates.. Mol Pharmacol. 69(1):165-73.
Liantonio A, Accardi A, Carbonara G, Fracchiolla G, Loiodice F, Tortorella P, Traverso S, Guida P, Pierno S, De Luca A et al..  2002.  Molecular requisites for drug binding to muscle CLC-1 and renal CLC-K channel revealed by the use of phenoxy-alkyl derivatives of 2-(p-chlorophenoxy)propionic acid.. Mol Pharmacol. 62(2):265-71.
Lien CA.  2010.  Neostigmine: how much is necessary for patients who receive a nondepolarizing neuromuscular blocking agent? Anesthesiology. 112(1):16-8.
Lien CA, Savard P, Belmont M, Sunaga H, Savarese JJ.  2009.  Fumarates: unique nondepolarizing neuromuscular blocking agents that are antagonized by cysteine.. J Crit Care. 24(1):50-7.
Lindenmuth DM, van Wijnen AJ, Hiebert S, Stein JL, Lian JB, Stein GS.  1997.  Subcellular partitioning of transcription factors during osteoblast differentiation: developmental association of the AML/CBF alpha/PEBP2 alpha-related transcription factor-NMP-2 with the nuclear matrix.. J Cell Biochem. 66(1):123-32.
Lingamaneni R, Hemmings HC.  2003.  Differential interaction of anaesthetics and antiepileptic drugs with neuronal Na+ channels, Ca2+ channels, and GABA(A) receptors.. Br J Anaesth. 90(2):199-211.
Lingamaneni R, Birch ML, Hemmings HC.  2001.  Widespread inhibition of sodium channel-dependent glutamate release from isolated nerve terminals by isoflurane and propofol.. Anesthesiology. 95(6):1460-6.
Lingamaneni R, Hemmings HC.  1999.  Effects of anticonvulsants on veratridine- and KCl-evoked glutamate release from rat cortical synaptosomes.. Neurosci Lett. 276(2):127-30.
Lingamaneni R, Krasowski MD, Jenkins A, Truong T, Giunta AL, Blackbeer J, MacIver MB, Harrison NL, Hemmings HC.  2001.  Anesthetic properties of 4-iodopropofol: implications for mechanisms of anesthesia.. Anesthesiology. 94(6):1050-7.
Lingameneni R, Vysotskaya TN, Duch DS, Hemmings HC.  2000.  Inhibition of voltage-dependent sodium channels by Ro 31-8220, a 'specific' protein kinase C inhibitor.. FEBS Lett. 473(2):265-8.
Liou J-Y, M Maciver B, Sleigh JW.  2025.  Solving the enigma of burst suppression.. Br J Anaesth. 134(4):900-902.
Lolicato M, Riegelhaupt PM, Arrigoni C, Clark KA, Minor DL.  2014.  Transmembrane helix straightening and buckling underlies activation of mechanosensitive and thermosensitive K(2P) channels.. Neuron. 84(6):1198-212.
Lyashchenko AK, Redd KJ, Goldstein PA, Tibbs GR.  2014.  cAMP control of HCN2 channel Mg2+ block reveals loose coupling between the cyclic nucleotide-gating ring and the pore.. PLoS One. 9(7):e101236.